Luis Borges is Chief Scientific Officer of Century Therapeutics, Inc.. Currently has a direct ownership of 256,535 shares of IPSC, which is worth approximately $282,188. The most recent transaction as insider was on Apr 03, 2023, when has been sold 7,452 shares (Common Stock) at a price of $1.03 per share, resulting in proceeds of $7,675. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 257K
0% 3M change
0% 12M change
Total Value Held $282,188

Luis Borges Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 03 2023
BUY
Exercise of conversion of derivative security
$7,675 $1.03 p/Share
7,452 Added 2.82%
256,535 Common Stock
Mar 23 2023
SELL
Open market or private sale
$55,369 $3.55 p/Share
15,597 Reduced 5.89%
249,083 Common Stock
Mar 23 2023
BUY
Exercise of conversion of derivative security
$227,557 $1.03 p/Share
220,930 Added 45.5%
264,680 Common Stock
Mar 22 2023
SELL
Open market or private sale
$244,396 $3.72 p/Share
65,698 Reduced 60.03%
43,750 Common Stock
Mar 22 2023
BUY
Exercise of conversion of derivative security
$67,668 $1.03 p/Share
65,698 Added 37.51%
109,448 Common Stock
Mar 21 2023
SELL
Open market or private sale
$239,832 $3.77 p/Share
63,616 Reduced 59.25%
43,750 Common Stock
Mar 21 2023
BUY
Exercise of conversion of derivative security
$65,524 $1.03 p/Share
63,616 Added 37.21%
107,366 Common Stock
Feb 02 2023
BUY
Grant, award, or other acquisition
-
43,750 Added 50.0%
43,750 Common Stock

Also insider at

MGX
Metagenomi, Inc.
LB

Luis Borges

Chief Scientific Officer
Philadelphia, PA

Track Institutional and Insider Activities on IPSC

Follow Century Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IPSC shares.

Notify only if

Insider Trading

Get notified when an Century Therapeutics, Inc. insider buys or sells IPSC shares.

Notify only if

News

Receive news related to Century Therapeutics, Inc.

Track Activities on IPSC